Trulieve Announced Week of Dispensary Reopenings Across Florida

TALLAHASSEE, Fla. – Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF), operator (MSO) in the United States, announced the reopening of four dispensaries formerly branded as Harvest House of Cannabis in Jacksonville, Gainesville, Kissimmee, and West Palm Beach, Florida. The locations join the Company’s 94 medical marijuana dispensaries statewide.

The reopenings follow the Company’s October 1, 2021 announcement of its closing the acquisition of Harvest Health and Recreation Inc., at which time all Harvest locations in Florida were closed for rebranding to Trulieve. The Company will continue to reopen locations in Florida throughout the month of October.

Trulieve welcomes the surrounding communities to join in celebrating the reopening of these dispensaries with all-day deals and swag giveaways. All patients, from those new to Trulieve to the dedicated Trulieve community, will be eligible for a 25% in-store discount at the new dispensaries on opening day.

ANNOUNCING: Trulieve Jacksonville Dispensary Reopening
WHERE: 10095 Beach Blvd., Suite 450 Jacksonville, FL
WHEN: Wednesday, October 13, 2021 at 9:00am

ANNOUNCING: Trulieve Gainesville Dispensary Reopening
WHERE: 3833-3841 SW Archer Road Gainesville, FL
WHEN: Thursday, October 14, 2021 at 9:00 am

ANNOUNCING: Kissimmee/E Irlo location Reopening 
WHERE: 2631 E Irlo Bronson Memorial Hwy Kissimmee, FL
WHEN: Friday, October 15, 2021 at 9:00 am

ANNOUNCING: Trulieve West Palm Beach Dispensary Reopening
WHERE: 4139 Okeechobee Blvd. West Palm Beach, FL
WHEN: Monday, October 18, 2021 at 9:00 am

In stores and online, patients will find Florida’s largest selection of THC and CBD products in a variety of delivery methods, including edibles, smokable flower, concentrates, tinctures, topical creams, vaporizers, and more. Trulieve also offers statewide home delivery, convenient online ordering and in-store pickup.

(This information is primarily sourced from Trulieve Cannabis Corp..  Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).